BioSmart Statistics

Total Valuation

BioSmart has a market cap or net worth of KRW 70.52 billion. The enterprise value is 132.63 billion.

Market Cap	70.52B
Enterprise Value	132.63B

Important Dates

The last earnings date was Friday, November 14, 2025.

Earnings Date	Nov 14, 2025
Ex-Dividend Date	n/a

Share Statistics

BioSmart has 25.27 million shares outstanding. The number of shares has increased by 10.43% in one year.

Current Share Class	25.27M
Shares Outstanding	25.27M
Shares Change (YoY)	+10.43%
Shares Change (QoQ)	+0.38%
Owned by Insiders (%)	24.54%
Owned by Institutions (%)	0.22%
Float	18.81M

Valuation Ratios

The trailing PE ratio is 9.73.

PE Ratio	9.73
Forward PE	n/a
PS Ratio	0.15
PB Ratio	0.39
P/TBV Ratio	0.53
P/FCF Ratio	3.76
P/OCF Ratio	2.94
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 4.13, with an EV/FCF ratio of 7.07.

EV / Earnings	18.38
EV / Sales	0.28
EV / EBITDA	4.13
EV / EBIT	5.52
EV / FCF	7.07

Financial Position

The company has a current ratio of 1.86, with a Debt / Equity ratio of 0.37.

Current Ratio	1.86
Quick Ratio	0.50
Debt / Equity	0.37
Debt / EBITDA	2.07
Debt / FCF	3.52
Interest Coverage	8.21

Financial Efficiency

Return on equity (ROE) is 4.51% and return on invested capital (ROIC) is 6.34%.

Return on Equity (ROE)	4.51%
Return on Assets (ROA)	5.34%
Return on Invested Capital (ROIC)	6.34%
Return on Capital Employed (ROCE)	11.76%
Revenue Per Employee	2.81B
Profits Per Employee	42.69M
Employee Count	169
Asset Turnover	1.71
Inventory Turnover	7.72

Taxes

In the past 12 months, BioSmart has paid 6.33 billion in taxes.

Income Tax	6.33B
Effective Tax Rate	46.32%

Stock Price Statistics

The stock price has decreased by -7.62% in the last 52 weeks. The beta is 0.57, so BioSmart's price volatility has been lower than the market average.

Beta (5Y)	0.57
52-Week Price Change	-7.62%
50-Day Moving Average	2,834.00
200-Day Moving Average	3,141.15
Relative Strength Index (RSI)	51.30
Average Volume (20 Days)	53,275

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, BioSmart had revenue of KRW 475.03 billion and earned 7.22 billion in profits. Earnings per share was 286.64.

Revenue	475.03B
Gross Profit	85.51B
Operating Income	23.70B
Pretax Income	13.67B
Net Income	7.22B
EBITDA	31.82B
EBIT	23.70B
Earnings Per Share (EPS)	286.64

Full Income Statement

Balance Sheet

The company has 43.17 billion in cash and 66.00 billion in debt, giving a net cash position of -22.83 billion or -903.13 per share.

Cash & Cash Equivalents	43.17B
Total Debt	66.00B
Net Cash	-22.83B
Net Cash Per Share	-903.13
Equity (Book Value)	178.85B
Book Value Per Share	5,527.27
Working Capital	74.60B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 23.95 billion and capital expenditures -5.19 billion, giving a free cash flow of 18.76 billion.

Operating Cash Flow	23.95B
Capital Expenditures	-5.19B
Free Cash Flow	18.76B
FCF Per Share	742.21

Full Cash Flow Statement

Margins

Gross margin is 18.00%, with operating and profit margins of 4.99% and 1.52%.

Gross Margin	18.00%
Operating Margin	4.99%
Pretax Margin	2.88%
Profit Margin	1.52%
EBITDA Margin	6.70%
EBIT Margin	4.99%
FCF Margin	3.95%

Dividends & Yields

BioSmart does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-10.43%
Shareholder Yield	-10.43%
Earnings Yield	10.23%
FCF Yield	26.60%

Stock Splits

The last stock split was on September 20, 2010. It was a reverse split with a ratio of 0.16667.

Last Split Date	Sep 20, 2010
Split Type	Reverse
Split Ratio	0.16667

Scores

BioSmart has an Altman Z-Score of 2.94 and a Piotroski F-Score of 7. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.94
Piotroski F-Score	7